Announcement on Tax Payment Remediation
Filed with SSE · · 1 page · Chinese
Chengdu Olymvax Biopharmaceuticals Inc. on 6ix
Earlier from Chengdu Olymvax Biopharmaceuticals
- Announcement on Pledge of Some Shares Held by Shareholder with Over 5% Shares
- Announcement on Release of Pledge of Partial Shares Held by Shareholders with Over 5% Shares
- Announcement on Expiration of Shareholding Reduction Period and Result of No Share Reduction by Shareholders with over 5% Shares
- Report for Q1 2026
- Announcement on Resolutions of the 2025 Annual General Meeting
Later from Chengdu Olymvax Biopharmaceuticals
- Announcement on the Implementation of Repurchase and Cancellation of the Class A Restricted Shares Initially Granted under the 2023 Restricted Stock Incentive Plan
- Announcement on Receiving Government Subsidies
- Announcement on Voluntary Disclosure of Winning the Second Prize of the 2025 National Technological Invention Award
- Voluntary Disclosure Announcement on the Unblinding Results of the Phase III Clinical Trial of Recombinant Staphylococcus Aureus Vaccine (E. coli)
- Announcement on Release of Pledge of Certain Shares Held by Shareholders Holding More Than 5% of the Shares
Follow Chengdu Olymvax Biopharmaceuticals into a list and get an email when it puts out news.
Follow Chengdu Olymvax Biopharmaceuticals